S&P 500   3,375.79 (+0.07%)
DOW   27,944.00 (+0.17%)
QQQ   272.33 (-0.06%)
AAPL   458.84 (-0.26%)
MSFT   208.88 (+0.09%)
FB   261.01 (-0.11%)
GOOGL   1,511.25 (-0.36%)
AMZN   3,149.86 (-0.35%)
NVDA   460.35 (+0.57%)
CGC   17.24 (-0.46%)
BABA   252.38 (-0.53%)
TSLA   1,640.50 (+1.20%)
GE   6.65 (+0.76%)
MU   46.03 (-0.24%)
AMD   81.05 (-0.97%)
T   30.05 (+0.47%)
F   7.08 (+0.71%)
ACB   10.83 (+6.39%)
GILD   68.69 (+0.75%)
NFLX   482.15 (+0.17%)
DIS   130.37 (-0.45%)
BAC   26.56 (+0.80%)
BA   177.49 (+1.58%)
S&P 500   3,375.79 (+0.07%)
DOW   27,944.00 (+0.17%)
QQQ   272.33 (-0.06%)
AAPL   458.84 (-0.26%)
MSFT   208.88 (+0.09%)
FB   261.01 (-0.11%)
GOOGL   1,511.25 (-0.36%)
AMZN   3,149.86 (-0.35%)
NVDA   460.35 (+0.57%)
CGC   17.24 (-0.46%)
BABA   252.38 (-0.53%)
TSLA   1,640.50 (+1.20%)
GE   6.65 (+0.76%)
MU   46.03 (-0.24%)
AMD   81.05 (-0.97%)
T   30.05 (+0.47%)
F   7.08 (+0.71%)
ACB   10.83 (+6.39%)
GILD   68.69 (+0.75%)
NFLX   482.15 (+0.17%)
DIS   130.37 (-0.45%)
BAC   26.56 (+0.80%)
BA   177.49 (+1.58%)
S&P 500   3,375.79 (+0.07%)
DOW   27,944.00 (+0.17%)
QQQ   272.33 (-0.06%)
AAPL   458.84 (-0.26%)
MSFT   208.88 (+0.09%)
FB   261.01 (-0.11%)
GOOGL   1,511.25 (-0.36%)
AMZN   3,149.86 (-0.35%)
NVDA   460.35 (+0.57%)
CGC   17.24 (-0.46%)
BABA   252.38 (-0.53%)
TSLA   1,640.50 (+1.20%)
GE   6.65 (+0.76%)
MU   46.03 (-0.24%)
AMD   81.05 (-0.97%)
T   30.05 (+0.47%)
F   7.08 (+0.71%)
ACB   10.83 (+6.39%)
GILD   68.69 (+0.75%)
NFLX   482.15 (+0.17%)
DIS   130.37 (-0.45%)
BAC   26.56 (+0.80%)
BA   177.49 (+1.58%)
S&P 500   3,375.79 (+0.07%)
DOW   27,944.00 (+0.17%)
QQQ   272.33 (-0.06%)
AAPL   458.84 (-0.26%)
MSFT   208.88 (+0.09%)
FB   261.01 (-0.11%)
GOOGL   1,511.25 (-0.36%)
AMZN   3,149.86 (-0.35%)
NVDA   460.35 (+0.57%)
CGC   17.24 (-0.46%)
BABA   252.38 (-0.53%)
TSLA   1,640.50 (+1.20%)
GE   6.65 (+0.76%)
MU   46.03 (-0.24%)
AMD   81.05 (-0.97%)
T   30.05 (+0.47%)
F   7.08 (+0.71%)
ACB   10.83 (+6.39%)
GILD   68.69 (+0.75%)
NFLX   482.15 (+0.17%)
DIS   130.37 (-0.45%)
BAC   26.56 (+0.80%)
BA   177.49 (+1.58%)
Log in

NYSE:HRCHill-Rom Stock Price, Forecast & News

$95.73
-0.57 (-0.59 %)
(As of 08/14/2020 01:37 PM ET)
Add
Compare
Today's Range
$95.50
Now: $95.73
$96.89
50-Day Range
$94.75
MA: $107.64
$117.57
52-Week Range
$72.29
Now: $95.73
$117.68
Volume2,783 shs
Average Volume676,278 shs
Market Capitalization$6.38 billion
P/E Ratio30.88
Dividend Yield0.91%
Beta0.65
Hill-Rom Holdings, Inc. operates as a medical technology company worldwide. It operates in three segments: Patient Support Systems, Front Line Care, and Surgical Solutions. The company offers medical surgical beds, intensive care unit beds, and bariatric patient beds, lifts and other patient mobility devices, non-invasive therapeutic products and surfaces, and information technologies and software solutions; and medical equipment management services, as well as sells equipment service contracts for its capital equipment. It also provides patient monitoring and diagnostics products, such as blood pressure, physical assessment, vital signs monitoring, diagnostic cardiopulmonary, diabetic retinopathy screening, and thermometry products; and respiratory health products comprising Vest System, VitalCough System, MetaNeb System, and Monarch systems to assist patients in the mobilization of retained blockages. In addition, the company offers surgical solutions that include surgical tables, lights, and pendants; positioning devices for use in shoulder, hip, spinal, and lithotomy surgeries, as well as platform-neutral positioning accessories for operating room tables; and operating room surgical safety and accessory products, which comprise scalpels and blades, light handle systems, skin markers, and other disposable products. Further, it is involved in the sales and rental of products to acute and extended care facilities through direct sales force and distributors; sales and rental of products directly to patients in the home; and sales to primary care facilities through distributors. Additionally, the company offers continuum of clinical care, including acute care and primary care, as well as clinical research organizations. Hill-Rom Holdings, Inc. was founded in 1969 and is headquartered in Chicago, Illinois.
Read More
Hill-Rom logo

Beat the Market (BTM) Rank

Analyst Opinion: 3.5Community Rank: 2.5Dividend Strength: 1.7Insider Behavior: 1.0Valuation: 0.6 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.86 out of 5 stars


Industry, Sector and Symbol

Industry Surgical & medical instruments
Sub-IndustryHealth Care Equipment
SectorMedical
CUSIP43147510
Phone312-819-7200

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$2.91 billion
Cash Flow$8.22 per share
Book Value$23.55 per share

Profitability

Net Income$152.20 million

Miscellaneous

Employees10,000
Market Cap$6.38 billion
Next Earnings Date11/6/2020 (Estimated)
OptionableOptionable
$95.73
-0.57 (-0.59 %)
(As of 08/14/2020 01:37 PM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive HRC News and Ratings via Email

Sign-up to receive the latest news and ratings for HRC and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Hill-Rom (NYSE:HRC) Frequently Asked Questions

How has Hill-Rom's stock price been impacted by Coronavirus (COVID-19)?

Hill-Rom's stock was trading at $89.15 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, HRC shares have increased by 7.4% and is now trading at $95.73.
View which stocks have been most impacted by COVID-19
.

Do Wall Street analysts recommend investors buy shares of Hill-Rom?

6 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Hill-Rom in the last year. There are currently 6 buy ratings for the stock, resulting in a consensus recommendation of "Buy."
View analyst ratings for Hill-Rom
.

When is Hill-Rom's next earnings date?

Hill-Rom is scheduled to release its next quarterly earnings announcement on Friday, November 6th 2020.
View our earnings forecast for Hill-Rom
.

How were Hill-Rom's earnings last quarter?

Hill-Rom Holdings, Inc. (NYSE:HRC) posted its quarterly earnings data on Friday, July, 31st. The medical technology company reported $1.95 earnings per share (EPS) for the quarter, topping the Zacks' consensus estimate of $1.46 by $0.49. The medical technology company had revenue of $767.50 million for the quarter, compared to analyst estimates of $749.39 million. Hill-Rom had a net margin of 7.05% and a return on equity of 25.48%. The company's revenue was up 5.6% compared to the same quarter last year. During the same period in the prior year, the firm earned $1.23 earnings per share.
View Hill-Rom's earnings history
.

How often does Hill-Rom pay dividends? What is the dividend yield for Hill-Rom?

Hill-Rom announced a quarterly dividend on Wednesday, July 15th. Investors of record on Friday, September 18th will be paid a dividend of $0.22 per share on Wednesday, September 30th. This represents a $0.88 dividend on an annualized basis and a dividend yield of 0.92%. The ex-dividend date is Thursday, September 17th.
View Hill-Rom's dividend history
.

What guidance has Hill-Rom issued on next quarter's earnings?

Hill-Rom issued an update on its FY 2020 Pre-Market earnings guidance on Friday, July, 31st. The company provided earnings per share (EPS) guidance of 5.40 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $5.54.

What price target have analysts set for HRC?

6 brokers have issued 12-month price targets for Hill-Rom's stock. Their forecasts range from $112.00 to $138.00. On average, they expect Hill-Rom's share price to reach $124.00 in the next year. This suggests a possible upside of 29.5% from the stock's current price.
View analysts' price targets for Hill-Rom
.

Has Hill-Rom been receiving favorable news coverage?

Media stories about HRC stock have been trending somewhat negative recently, InfoTrie reports. The research group ranks the sentiment of media coverage by analyzing more than six thousand blog and news sources in real time. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores nearest to five being the most favorable. Hill-Rom earned a news impact score of -1.6 on InfoTrie's scale. They also assigned news articles about the medical technology company a news buzz of 10.0 out of 10, indicating that recent media coverage is extremely likely to have an effect on the company's share price in the next few days.
View the latest news about Hill-Rom
.

Are investors shorting Hill-Rom?

Hill-Rom saw a increase in short interest in the month of June. As of June 30th, there was short interest totaling 2,150,000 shares, an increase of 25.7% from the June 15th total of 1,710,000 shares. Based on an average daily trading volume, of 679,200 shares, the short-interest ratio is presently 3.2 days. Currently, 3.2% of the shares of the stock are short sold.
View Hill-Rom's Short Interest
.

Who are some of Hill-Rom's key competitors?

What other stocks do shareholders of Hill-Rom own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Hill-Rom investors own include Steel Dynamics (STLD), Walt Disney (DIS), Paypal (PYPL), Square (SQ), NVIDIA (NVDA), Micron Technology (MU), Twilio (TWLO), salesforce.com (CRM), CVS Health (CVS) and Mastercard (MA).

Who are Hill-Rom's key executives?

Hill-Rom's management team includes the following people:
  • Mr. John P. Groetelaars, Pres, CEO & Director (Age 52)
  • Mr. Carlos Alonso-Marum, Sr. VP & Pres of International (Age 60)
  • Mr. Paul Johnson, Sr. VP & Pres of Patient Support Systems (Age 54)
  • Mr. Steven J. Strobel, Sr. Advisor (Age 61)
  • Ms. Barbara W. Bodem, Sr. VP & CFO (Age 51)

What is Hill-Rom's stock symbol?

Hill-Rom trades on the New York Stock Exchange (NYSE) under the ticker symbol "HRC."

Who are Hill-Rom's major shareholders?

Hill-Rom's stock is owned by many different institutional and retail investors. Top institutional investors include Vanguard Group Inc. (9.43%), Victory Capital Management Inc. (3.22%), FMR LLC (1.41%), Bank of New York Mellon Corp (1.25%), Fisher Asset Management LLC (1.12%) and Ceredex Value Advisors LLC (0.79%). Company insiders that own Hill-Rom stock include Amy M Dodrill, Andreas G Frank, Deborah Rasin, Mary Kay Ladone and Paul Sherwood Johnson.
View institutional ownership trends for Hill-Rom
.

Which institutional investors are selling Hill-Rom stock?

HRC stock was sold by a variety of institutional investors in the last quarter, including Bank of Montreal Can, FMR LLC, Bank of New York Mellon Corp, Jennison Associates LLC, Vanguard Group Inc., Wedge Capital Management L L P NC, Fisher Asset Management LLC, and Strs Ohio. Company insiders that have sold Hill-Rom company stock in the last year include Amy M Dodrill, Andreas G Frank, Deborah Rasin, Mary Kay Ladone, and Paul Sherwood Johnson.
View insider buying and selling activity for Hill-Rom
.

Which institutional investors are buying Hill-Rom stock?

HRC stock was purchased by a variety of institutional investors in the last quarter, including Holocene Advisors LP, Victory Capital Management Inc., LSV Asset Management, Silvercrest Asset Management Group LLC, Candriam Luxembourg S.C.A., Bellevue Group AG, Retirement Systems of Alabama, and Nordea Investment Management AB.
View insider buying and selling activity for Hill-Rom
.

How do I buy shares of Hill-Rom?

Shares of HRC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Hill-Rom's stock price today?

One share of HRC stock can currently be purchased for approximately $95.73.

How big of a company is Hill-Rom?

Hill-Rom has a market capitalization of $6.38 billion and generates $2.91 billion in revenue each year. The medical technology company earns $152.20 million in net income (profit) each year or $5.08 on an earnings per share basis. Hill-Rom employs 10,000 workers across the globe.

What is Hill-Rom's official website?

The official website for Hill-Rom is www.hill-rom.com.

How can I contact Hill-Rom?

Hill-Rom's mailing address is 130 East Randolph Street Suite 1000, Chicago IL, 60601. The medical technology company can be reached via phone at 312-819-7200 or via email at [email protected]

This page was last updated on 8/14/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.